News

1/13/25: Read an OPTN data monitoring report for 18 months of lung allocation, which is operating under a new framework called continuous distribution (CD).

1/10/25: Learn how OPTN requirements may be amended regarding HOPE Act provisions, pursuant to a Department of Health and Human Services (HHS) directive.

1/10/25: Learn about positive highlights from a data report on changes made to the deceased donor registration form.

1/2/25: Read about the Spring 2025 special election of a new Board of Directors to advance the OPTN Modernization Initiative and Securing the U.S. OPTN Act.

12/27/24: Read a patient safety notice announcing an Astellas Pharma recall of certain lots of immunosuppressant capsules.

12/26/24: Read a message from Richard Formica, M.D., the OPTN Board President, regarding organ donation process questions.

12/18/24: Read an update from Richard Formica, M.D., OPTN President, on the HRSA directive that calls for new OPTN data collection.

12/9/24: Learn about updates to bylaws and new procedures for OPTN computer system access approved by the OPTN Board of Directors.

12/6/24: Learn about HRSA's plans to form a Transitional Nominating Committee for a new OPTN Board of Directors and about the professional expertise it seeks.

12/5/24: The OPTN Board of Directors has selected Rexanah Wyse Morrissette, Esq., as the OPTN’s Interim Executive Director after a national search.